Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

UNBELIEVABLE: 2 | History Defined

Looking Into Alnylam Pharmaceuticals's Return On Capital Employed

Benzinga Pro data, Alnylam Pharmaceuticals (NASDAQ:ALNY) reported Q4 sales of $258.54 million. Earnings fell to a loss of $258.46 million, resulting in a 26.38% decrease from last quarter.

Benzinga · Feb 11, 2022

Expert Ratings For Alnylam Pharmaceuticals

Expert Ratings For Alnylam Pharmaceuticals

Analysts have provided the following ratings for Alnylam Pharmaceuticals (NASDAQ:ALNY) within the last quarter:

Benzinga · Feb 11, 2022

Alnylam Clocks 76% Increase In Q4 Product Sales, Expects FY22 Product Sales Of Up To $1B

Alnylam Clocks 76% Increase In Q4 Product Sales, Expects FY22 Product Sales Of Up To $1B

Alnylam Pharmaceuticals Inc's (NASDAQ: ALNY)

Benzinga · Feb 10, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Alnylam Pharmaceuticals: Q4 Earnings Insights

Alnylam Pharmaceuticals (NASDAQ:ALNY) reported its Q4 earnings results on Thursday, February 10, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Benzinga · Feb 10, 2022

A Bearish Sign Appears On Alnylam Pharmaceuticals's Chart

If history is any guide, there may be trouble ahead for shares of Alnylam Pharmaceuticals (NASDAQ:ALNY). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.

Benzinga · Jan 21, 2022

Alnylam' Reveals Detailed 18-Month Data From Vutrisiran Trial In Inherited Disease

Alnylam Pharmaceuticals Inc (NASDAQ: ALNY) has announced

Benzinga · Jan 21, 2022

What 10 Analyst Ratings Have To Say About Alnylam Pharmaceuticals

Over the past 3 months, 10 analysts have published their opinion on Alnylam Pharmaceuticals (NASDAQ:ALNY) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga · Jan 20, 2022

inkl

Read news from The Economist, FT, and more,
with one subscription

1 2

Coverage From

Organisations

Alnylam Pharmaceuticals

Alnylam Pharmaceuticals Inc

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play